Skip to main content
Bio Solution Co.,Ltd. logo

Bio Solution Co.,Ltd. — Investor Relations & Filings

Ticker · 086820 ISIN · KR7086820008 KO Manufacturing
Open in API
Filings indexed 214 across all filing types
Latest filing 2020-10-22 Regulatory Filings
Country KR South Korea
Listing KO 086820

About Bio Solution Co.,Ltd.

https://bio-solution.co.kr/

Bio Solution Co., Ltd. is a biotechnology company focused on the development, manufacturing, and sale of cell therapy products. The company's core activities involve cell-based biotechnology, producing therapeutics such as autologous chondrocyte treatments for cartilage regeneration. In addition to its therapeutic offerings, Bio Solution develops human tissue models and provides alternative testing solutions. The company also manufactures and distributes a portfolio of bio-laboratory products, including ready-to-use kits, staining solutions, and various reagents for molecular biology research and development applications.

Recent filings

Filing Released Lang Actions
기타경영사항(특허권취득)(자율공시)(유체 샘플로부터 세포 외 소포체를 고농축하는 크기 기반 분리법)
Regulatory Filings Classification · 1% confidence The document is a voluntary disclosure (자율공시) regarding the acquisition of a patent by BioSolution. It details the patent name, content, and application plan. Since it is a regulatory announcement of a specific corporate event (patent acquisition) that does not fit into financial reporting or other specific categories, it falls under the general regulatory filing category.
2020-10-22 Korean
기타경영사항(특허권취득)(자율공시)(물질 P를 포함하는 난치성 궤양 치료용 조성물)
Regulatory Filings Classification · 1% confidence The document is a voluntary disclosure (자율공시) regarding the acquisition of a patent (특허권 취득) by BioSolution. It details the patent name, content, and utilization plan. Since it does not fit into specific categories like financial reports, M&A, or director dealings, and is a standard regulatory disclosure of a corporate event, it falls under the general regulatory filing category.
2020-09-17 Korean
반기보고서 (2020.06)
Interim / Quarterly Report Classification · 1% confidence The document is a '반기보고서' (Semi-Annual Report) for the company 'Biosolution Co., Ltd.' covering the period from January 1, 2020, to June 30, 2020. It contains comprehensive financial statements, management discussion and analysis, and corporate governance information, which aligns with the definition of an Interim/Quarterly Report (IR). H1 2020
2020-08-14 Korean
분기보고서 (2020.03)
Interim / Quarterly Report Classification · 1% confidence The document is a '분기보고서' (Quarterly Report) for the company '주식회사바이오솔루션' (Biosolution Co., Ltd.) covering the period from 2020-01-01 to 2020-03-31. It contains detailed financial statements, management discussion, and corporate governance information, which aligns with the definition of an Interim/Quarterly Report (IR). Q1 2020
2020-05-15 Korean
기타경영사항(자율공시)(국책과제 선정(보건복지부 첨단의료기술개발))
Regulatory Filings Classification · 1% confidence The document is a voluntary disclosure (자율공시) regarding the selection of a government-funded research project (국책과제 선정) by the Ministry of Health and Welfare for the company BioSolution. It details the project name, duration, funding amounts, and expected outcomes. Since this is a specific corporate announcement regarding business operations and research developments that does not fit into financial reporting, dividend, or governance categories, it is classified as a general regulatory filing.
2020-04-27 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 1% confidence The document is an official announcement of the results of a General Meeting of Shareholders (AGM). It details the approval of financial statements, director appointments, and other resolutions passed during the meeting held on 2020-03-30. This falls under the category of Declaration of Voting Results & Voting Rights Announcements.
2020-03-30 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.